Psychosis Clinical Trials in Columbus, Ohio
4 recruitingColumbus, Ohio
Showing 1–4 of 4 trials
Recruiting
Phase 3
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company800 enrolled428 locationsNCT05980949
Recruiting
Phase 1Phase 2
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR)
Monument Therapeutics Limited150 enrolled15 locationsNCT07226895
Recruiting
Phase 2
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.180 enrolled56 locationsNCT07029581
Recruiting
Not Applicable
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
SchizophreniaPsychosisFirst-episode Psychosis
Nicholas Breitborde20 enrolled1 locationNCT04368039